На главную / Научное направление / Лаборатории / Лаборатория молекулярно-генетических исследований терапевтических заболеваний /

Статьи и тезисы

  1. Striukova E.V., Maksimov V.N., Ragino Yu.I., Polonskaya Ya.V., Murashov I.S., Volkov A.M., Kurguzov A.V., Chernjavskii A.M., Kashtanova E.V. Polymorphisms in the CETP, APOC3 and APOE genes in men with unstable atherosclerotic plaques in the coronary arteries. Meta Gene. 2021;27:100847. doi: 10.1016/j.mgene.2020.100847.
  2. Voropaeva E.N., Orlov Y.L., Pospelova T.I., Gurazheva A.A., Voevoda M.I., Maksimov V.N., Seregina O.B., Churkina M.I. The rs78378222 prevalence and the copy loss of the protective allele A in the tumor tissue of diffuse large B-cell lymphoma. PeerJ. 2020;8. doi: 10.7717/peerj.10335.
  3. Maximov V., Malyutina S., Orlov P., Ivanoschuk D., Mikhailova S.V., Shapkina M.Yu., Hubacek J., Holmes M., Bobak M., Voevoda M. Copy Number of the Mitochondrial DNA of Leucocytes as an Aging Marker and Risk Factors for the Development of Age-Related Diseases in Humans. Advances in Gerontology. 2020;10(1):1-8. doi: 10.1134/S2079057020010129.
  4. Leberfarb E.Y., Degtyareva A.O., Brusentsov I.I., Maximov V.N., Voevoda M.I., Autenshlus A.I., Morozov D.V., Sokolov A.V., Merkulova T.I. Potential regulatory SNPs in the ATXN7L3B and KRT15 genes are associated with gender-specific colorectal cancer risk. Per Med. 2020;17(1):43-54. doi: 10.2217/pme-2019-0059.
  5. Nikulina S.Yu., Artyukhov I.P., Shesternya P.A., Gavrilyuk O.A., Maksimov V.N., Voyevoda M.I., Brusentsov D.A. Clinical application of chromosome 9p21.3 genotyping in patients with coronary artery disease. Experimental and therapeutic medicine. 2019;18(4):3100-3108. doi: 10.3892/etm.2019.7884.
  6. Aftanas L.I., Anisimenko M.S., Berdyugina D.A., Garanin A.Yu., Maximov V.N., Voevoda M.I., Vyalova N.M., Bokhan N.A., Ivanova S.A., Danilenko K.V., Kovalenko S.P. SIRT1 allele frequencies in depressed patients of european descent in Russia. Frontiers in genetics. 2019;9:686. doi: 10.3389/fgene.2018.00686.
  7. Voropaeva E.N., Pospelova T.I., Voevoda M.I., Maksimov V.N., Orlov Y.L., Seregina O.B. Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma. BMC Med Genomics. 2019;12(Suppl 2):35. doi: 10.1186/s12920-019-0484-9.
  8. Yudin N.S., Barkhash A.V., Maksimov V.N., Ignatieva E.V., Romaschenko A.G. Human Genetic Predisposition to Diseases Caused by Viruses from Flaviviridae Family. Molecular Biology. 2018;52(2):165-181.
  9. Shakhtshneider E.V., Mikhailova S.V., Ivanoshchuk D.E., Orlov P.S., Ovsyannikova A.K., Rymar O.D., Ragino Yu.I., Voevoda M.I. Polymorphism of the GLIS3 gene in a caucasian population and among individuals with carbohydrate metabolism disorders in Russia. BMC Research Notes. 2018;11(1):211. doi: 10.1186/s13104-018-3338-1.
  10. Stefler D., Malyutina S., Maximov V., Orlov P., Ivanoschuk D., Nikitin Y., Gafarov V., Ryabikov A., Voevoda M., Bobak M., Holmes M. Leukocyte telomere length and risk of coronary heart disease and stroke mortality: prospective evidence from a russian cohort. Scientific Reports. 2018;8(1):1-6. doi: 10.1038/s41598-018-35122-y.
  11. Cherepkova E.V., Maksimov V.N., Aftanas L.I. Polymorphism of serotonin transporter gene in male subjects with antisocial behavior and MMA fighters. Transl Psychiatry. 2018;8(1):248. doi: 10.1038/s41398-018-0298-0.
  12. Ivanova A.A., Maksimov V.N., Ivanoshchuk D.E., Orlov P.S., Novoselov V.P., Savchenko S.V., Voevoda M.I. Association of Polymorphism in SCN5A, GJA5, and KCNN3 Gene with Sudden Cardiac Death. Bull Exp Biol Med. 2017;163(1):73-77.
  13. Voropaeva E.N., Voevoda M.I., Maksimov V.N., Pospelova T.I. Frequency, spectrum, and functional significance of TP53 mutations in patients with diffuse large B-cell lymphoma. Molecular Biology. 2017;51(1):53-60.
  14. Maximov V.N., Malyutina S.K., Orlov P.S., Ivanoschuk D.E., Voropaeva E.N., Bobak M., Voevoda M.I. Leukocyte Telomere Length as an Aging Marker and Risk Factor for Human Age-Related Diseases. Advances in Gerontology. 2017;7(2):101-106.
  15. Belyavskaya V.A., Prudnikova T.Y., Domanitskaya N.V., Litviakov N.V., Maksimov V.N., Cherdyntseva N.V., Grigorieva E.V. GLCE rs3865014 (Val597Ile) polymorphism is associated with breast cancer susceptibility and triple-negative breast cancer in Siberian population. Gene. 2017;628:224-229. doi: 10.1016/j.gene.2017.07.054.
  16. Cherepkova E., Maksimov V., Kushnarev A., Shakhmatov I., Aftanas L.I. The polymorphism of dopamine receptor D4 (DRD4) and dopamine transporter (DAT) genes in the men with antisocial behavior and mixed martial arts fighters. World J Biol Psychiatry. 2017:1-26. doi: 10.1080/15622975.2017.1366056.
  17. Cherdyntseva N., Gervas P., Denisov E., Pisareva L., Malinovskaya E., Choynzonov E., Voropaeva E., Maksimov V., Voevoda M., Cherdyntsev E., Perinov D., Panferova Y. New variants in the BRCA1 gene in buryatmongol breast cancer patients: report from two families. Cancer Biomarkers. 2017;18(3):291-296. doi: 10.3233/CBM-161649.
  18. Gubina M.A., Babenko V.N., Ivanoshchuk D.E., Shuryaeva A.K., Latieva O.O., Solov'eva I.G., Ponomareva M.N., Konovalova N.A., Maksimov V.N., Voevoda M.I. Polymorphism of the c-fms, ITGB3, CCR2, and DBH genes in the populations of old believers of the Tyumen oblast and Russian residents of Novosibirsk. Mol Biol (Mosk). 2016;50(2):246-254.
  19. Mikhailova S.V., Babenko V.N., Ivanoshchuk D.E., Gubina M.A., Maksimov V.N., Solovjova I.G., Voevoda M.I. Haplotype analysis of the HFE gene among populations of Northern Eurasia, in patients with metabolic disorders or stomach cancer, and in long-lived people. BMC Genet. 2016;17(1):83.
  20. Ivanova A.A., Maksimov V.N., Orlov P.S., Ivanoshchuk D.E., Savchenko S.V., Voevoda M.I. Association of the genetic markers for myocardial infarction with sudden cardiac death. Indian Heart J. 2016;68(Suppl 1)? . doi: 10.1016/j.ihj.2016.07.016.
  21. Apsalikov B., Manambaeva Z., Ospanov E., Massabayeva M., Zhabagin K., Zhagiparova Z., Maximov V., Voropaeva E., Apsalikov K., Belikhina T., Abdrahmanov R., Cherepkova E., Tanatarov S., Massadykov A., Urazalina N. BRCA1 and TP53 Gene-Mutations: Family Predisposition and Radioecological Risk of Developing Breast Cancer. Asian Pac J Cancer Prev. 2016;17(8):4059-4062.
  22. Striukova E.V., Maksimov V.N., Ragino Y.I., Polonskaya Y.V., Murashov I.S., Volkov A.M., Kurguzov A.V., Chernjavskii A.M., Kashtanova E.V. Polymorphisms in CCL2 and IL6 genes in men with unstable atherosclerotic plaques in the coronary arteries. Journal of Cardiovascular Disease Research. 2021;12(1):68-74. doi: 10.31838/jcdr.2021.12.01.16.
  23. Malyutina S., Chervova O., Tillmann T., Maximov V., Ryabikov A., Gafarov V., Hubacek J.A., Pikhart H., Beck S., Bobak M. The Relationship between Epigenetic Age and Myocardial Infarction/Acute Coronary Syndrome in a Population-Based Nested Case-Control Study. J. Pers. Med. 2022;12:110. doi: 10.3390/jpm12010110.
  24. Voropaeva E.N., Pospelova T.I., Orlov Y.L., Churkina M.I., Berezina O.V., Gurazheva A.A., Ageeva T.A., Seregina O.B., Maksimov V.N. The Methylation of the p53 Targets the Genes MIR-203, MIR-129-2, MIR-34A and MIR-34B/C in the Tumor Tissue of Diffuse Large B-Cell Lymphoma. Genes. 2022;13:1401. doi: 10.3390/genes13081401.
  25. Chervova O., Chernysheva E., Panteleeva K., Widayati T.A., Hrbkova N., Schneider J., Maximov V., Ryabikov A., Tillmann T., Pikhart H., Bobak M., Voloshin V., Malyutina S., Beck S. Evaluation of Epigenetic Age Acceleration Scores and Their Associations with CVD-Related Phenotypes in a Population Cohort. Biology. 2023;12(1):68. doi: 10.3390/biology12010068.
  26. Malyutina S.K., Maximov V.N., Chervova O., Orlov P.S., Voloshin V., Ryabikov A.N., Voevoda M.I., Nikitenko T.M. Leukocyte telomere length and mitochondrial DNA copy number association with colorectal cancer risk in an aging population. Global Translational Medicine. 2023;2(1):184. doi: 10.36922/gtm.v2i1.184.
  27. Malyutina S., Maximov V., Chervova O., Orlov P., Ivanova A., Mazdorova E., Ryabikov A., Simonova G., Voevoda M. The Relationship between All-Cause Natural Mortality and Copy Number of Mitochondrial DNA in a 15-Year Follow-Up Study. Int J Mol Sci. 2023;24(13):10469. doi: 10.3390/ijms241310469.
  28. Gafarov V.V., Gromova E.A., Tripelgorn A.N., Gagulin I.V., Maksimov V.N., Gafarova A.V. Circadian Rhythm Genes and Sleep Disorders in an Open Population of Men Aged 25–64 Years (an Epidemiological Study under the WHO MONICA-Psychosocial Program). Neuroscience and Behavioral Physiology. 2024;54(1):10-15. doi: 10.1007/s11055-024-01561-6. EDN PDPWAP.
  29. Malyutina S., Chervova O., Maximov V., Nikitenko T., Ryabikov A., Voevoda M. Blood-Based Epigenetic Age Acceleration and Incident Colorectal Cancer Risk: Findings from a Population-Based Case-Control Study. Int J Mol Sci. 2024;25(9):4850. doi: 10.3390/ijms25094850.
  30. Maksimov V.N., Minnikh S.V., Ivanova A.A. Modern approaches to the assessment of individual risk of CHD development: status, problems, prospects. Ateroscleroz. 2024;20(2):154-161. (In Russ.). doi: 10.52727/2078-256X-2024-20-2-154-1.
  31. Ivanova A.A., Apartseva N.E., Kashirina A.P., Nemcova E.G., Ivanova J.V., Kruchinina M.V., Kurilovich S.A., Maksimov V.N. Results of UGT1A1 gene sequencing in individuals with the Gilbert syndrome phenotype. Bulletin of Siberian Medicine. 2024;23(2):65-73. doi: 10.20538/1682-0363-2024-2-65-73.
  32. Ivanova A.A., Apartseva N.E., Kashirina A.P., Nemtsova E.G., Ivanova Y.V., Kruchinina M.V., Kurilovich S.A., Maksimov V.N. Detection of major mutations in CFTR, SERPINA1, HFE genes in benign unconjugated hyperbilirubinemia phenotype. Sovremennye tehnologii v medicine. 2024;16(4):38. doi: 10.17691/stm2024.16.4.04.
  33. Gafarov V.V., Gromova E.A., Gubina M.A., Gagulin I.V., Maksimov V.N., Gafarova A.V. Association of Polymorphisms of the Serotonin Transporter Gene SLC6A4 with Depression. Neuroscience and Behavioral Physiology. 2024;54(5):655-659. doi: 10.1007/s11055-024-01645-3. EDN YAIDXC.
  34. Voropaeva E.N., Orlov YL., Loginova A.B., Seregina O.B., Maksimov V.N., Pospelova T.I. Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma. PeerJ. 2025;13. doi: 10.7717/peerj.18661.
  35. Voropaeva E.N., Burundukova M.V., Lyzlova A.A., et al. Mutations in hotspot regions of FLT3, NPM1, IDH1, IDH2, and DNMT3A genes in patients with acute myeloid leukemia. Siberian Journal of Oncology. 2025;24(1):125-141. doi: 10.21294/1814-4861-2025-24-1-125-141.
  36. Ivanova Yu.V., Ivanova A.A., Maksimov V.N. Molecular genetic markers of Gilbert's syndrome. Terapevticheskiy Arkhiv (Therapy). 2025;11(4(86)):71-79. doi: 10.18565/therapy.2025.4.71-79.
  37. Voropaeva E.N., Burundukova M.V., Kuznetsova I.A., et al. Frequency and spectrum of insertions in exon 12 of the NPM1 gene in patients with de novo acute myeloid leukemia residing in a large Siberian metropolis. Siberian Scientific Medical Journal. 2025;45(4):171-180. doi: 10.18699/SSMJ20250418.
  38. Ivanova A.A. et al. Association of single nucleotide variants in the SLCO1B1 gene with the phenotypic manifestations of Gilbert's syndrome. Bulletin of Siberian Medicine. 2025;24(1):29-35. doi: 10.20538/1682-0363-2025-1-29-35.
  39. Maksimov V.N., Minnikh S.V., Ivanova Yu.V., et al. Association of the FTO gene rs9939609 polymorphism with different phenotypes of obesity in a female population. Doctor.Ru. 2025;24(4):43-50. doi: 10.31550/1727-2378-2025-24-4-43-50.
  40. Maksimov V.N., Minnikh S.V., Ivanova Yu.V. Some molecular genetic markers of obesity in women. Medical Genetics. 2025;24(7):48-50. doi: 10.25557/2073-7998.2025.07.48-50. EDN RUOEOW.
  41. Voropaeva E.N., Burundukova M.V., Kuznetsova I.A., et al. Analysis of cell-free DNA in the plasma of patients with acute myeloid leukemias: methodology and results. Clinical Oncohematology. 2025;18(4):347-354. doi: 10.21320/2500-2139-2025-18-4-347-354. EDN CWNMAV.
  42. Voropaeva E.N., Seregina O.B., Voytko M.S., et al. The role of microRNA miR-142 in tumor progression of diffuse large B-cell lymphoma. Oncohematology. 2025;20(2):87-103. doi: 10.17650/1818-8346-2025-20-2-87-103. EDN SVPQCY.
  43. Voropaeva E.N., Seregina O.B., Voytko M.S., et al. Frequency, spectrum, and functional significance of mutations in the MIR-142 gene in diffuse large B-cell lymphoma. In: Scientific Results of Biomedical Research. 2025;11(4):607-627. doi: 10.18413/2658-6533-2025-11-4-0-2.